DrugPatentWatch Report Store
Showing 385–396 of 905 results
- Drug Patent Reports
KOVANAZE (oxymetazoline hydrochloride; tetracaine hydrochloride) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
KRAZATI (adagrasib) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
KRINTAFEL (tafenoquine succinate) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
KYZATREX (testosterone undecanoate) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Excipient Business Development Opportunity Reports
LACTIC ACID Drug Excipient Business Development Opportunity Report, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Excipient Business Development Opportunity Reports
LACTOSE Drug Excipient Business Development Opportunity Report, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Excipient Business Development Opportunity Reports
LACTOSE MONOHYDRATE Drug Excipient Business Development Opportunity Report, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
LAMPIT (nifurtimox) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Excipient Business Development Opportunity Reports
LANOLIN ALCOHOLS Drug Excipient Business Development Opportunity Report, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Excipient Business Development Opportunity Reports
LAURAMINE OXIDE Drug Excipient Business Development Opportunity Report, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Excipient Business Development Opportunity Reports
LECITHIN, SOYBEAN Drug Excipient Business Development Opportunity Report, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
LENVIMA (lenvatinib mesylate) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now
